Nevertheless, the results observed here are clear, opening a venue to the search of these miRNAs as new biomarker candidates to monitor the etiological treatment in CD, especially for prognosis prediction and therapeutic cure in the chronic phase of CD101. This evidence concerns the gene CD101 and Cowden disease.